Corbus Pharmaceuticals Holdings, Inc. · NASDAQ:CRBP

Pfeiffenberger Brent received 7,500 Corbus Pharmaceuticals Holdings, Inc. shares as an award (Form 4)

Traded May 19, 2026 · Filed May 21, 2026

On May 19, 2026, Pfeiffenberger Brent (Director) received 7,500 Corbus Pharmaceuticals Holdings, Inc. shares as an award, leaving 7,500 shares. Filed May 21, 2026 (Form 4).

Awarded
7,500 shares
Holding after
7,500 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 19, 2026Common Stock, par value $0.0001 per shareAward7,5007,500Direct

Source

View original at SEC

Related